 Early treatment ischemic stroke calcium antagonist feasibility safety study II nicardipine calcium antagonist patients objectives study therapy possible equal hours onset ischemic stroke high dose possible patients intravenous infusion nicardipine hours dose mg/hr maximum dose mg/hr Upward titration dose decrease blood pressure beats/min increase pulse Intravenous therapy days oral therapy mean SD interval onset stroke commencement therapy hours Adverse reactions hypotension discontinuation therapy patients Score graded neurologic examination baseline months patients follow-up correlation dose nicardipine patients therapy equal hours onset therapy hours onset Further study early therapy nicardipine justified